The The rules that govern selection, segregation, and complementation of different mtDNA molecules at the intracellular and cell population levels are poorly understood. In mammalian cells, until recently, the available evidence was limited to the behavior of drug-resistance-inducing mutations in cell hybrids and cybrids (cells fused to cytoplasts), and pointed to a random drift to the mutant or wild-type genotype in the absence of selection (1) and to a propagative advantage of the resistance-conferring mutant mtDNA in the presence of the drug (1, 2). The recent identification of human disorders associated with mtDNA mutations (3) has provided an opportunity for investigating the transmission of natural mutations in the patient's cells in vivo or in their in vitro derivatives. Thus, an accumulation of deleted mtDNA molecules relative to coexisting wild-type genomes has been reported in skeletal muscle fibers of patients with mitochondrial diseases (4, 5) and in cybrids derived from patient's cells (6).
The rules that govern selection, segregation, and complementation of different mtDNA molecules at the intracellular and cell population levels are poorly understood. In mammalian cells, until recently, the available evidence was limited to the behavior of drug-resistance-inducing mutations in cell hybrids and cybrids (cells fused to cytoplasts), and pointed to a random drift to the mutant or wild-type genotype in the absence of selection (1) and to a propagative advantage of the resistance-conferring mutant mtDNA in the presence of the drug (1, 2) . The recent identification of human disorders associated with mtDNA mutations (3) has provided an opportunity for investigating the transmission of natural mutations in the patient's cells in vivo or in their in vitro derivatives. Thus, an accumulation of deleted mtDNA molecules relative to coexisting wild-type genomes has been reported in skeletal muscle fibers of patients with mitochondrial diseases (4, 5) and in cybrids derived from patient's cells (6) .
In the present work, cell lines containing in heteroplasmic form the mitochondrial tRNAI-u(uuR) gene mutation associated with the MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) (7) (8) (9) that were constructed by introducing patient mitochondria into human mtDNA-less (p0) cells (10) were used to investigate the behavior of mutant and wild-type mtDNAs upon prolonged subculturing. The MELAS mutation has been shown (11, 12) 
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Myobast Cultures and Mltochodrla.Meae p046 Cell TV.n~brnu~lon-Mass myoblast cultures were established from muscle biopsy specimens by using reported procedures (13) (14) (15) . Conditions of growth of the p026 cell line and p0206 cell transformation by cytoplast fusion were as described (16) . Transformants were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) dialyzed fetal calf serum and bromodeoxyuridine at 100 Ag/ml. The population doubling time of the transformants was determined from growth curves or by using the formula: (7) (8) (9) in a fragment amplfied by a PCR using oligonucleotides corresponding to positions 3031-3050 and 3341-3360. The proportion of digested and undigested molecules was determined by laser densitometry after ethidium bromide staining of the agarose gel. To correct for possible resistance to digestion of heteroduplexes of wild-type and mutant mtDNA formed during the final stages of PCR amplification (17), a mixed-template standard curve was constructed by PCR amplification of a mtDNA fiagment containing the mutation from total DNA samples of 43B cells, containing 99% mutated mtDNA, and transformant 94C, containing exclusively wild-type mtDNA (12) . Different ratio mixtures of the mutant and wild-type PCR products were then used for a second cycle of PCR amplification. Fig. 1 compares the mixed template standard curve (curve T) thus constructed with the mixed product standard curve (curve P), obtained by mixing the PCR products independently amplified from 43B-derived and 94C-derived PCR products in different ratios and then subjecting the mixtures to Apa I digestion.
Abbreviation: MELAS, mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Slot blot analysis of total DNA samples for quantitation of mtDNA was carried out as described (10) usi the mtDNA clone pTZ18/K4 (containing a fiagment from positions 41 to 2578), 32P-Iabeled by random prming (18) , as a probe. The data were normalized relative to hybridization to a nuclear 28S rRNA probe, constructed by PCR amplification from the 28S rRNA gene (19) . wild-type mtDNA, has been observed (12) . The present observations for 94B, therefore, fit in well with the above data. The finding that, in the 94B heteroplasmic transformant, the mtDNA shift to mutant type went beyond the threshold protective level of wild-type mtDNA, causing a defect in the respiratory capacity of the transformant to appear, indicates that this defect did not produce a significant growth disadvantage in the affected cells, probably due to an adaptation that allows the cells to rely on glycolysis for their energy requirements. The growth rate measurements discussed below support this conclusion.
RESULTS

Transfer
To investigate whether the unusual behavior ofthe mtDNA in the 94 transformants was related to some property of its sequence, genotypes of heteroplasmic transformants derived from other genetically unrelated MELAS patients were analyzed. As shown in Fig. 2 C, D , and E, transformants 2SE, 3E7, and 5X1 (derived from patients 2S, 3E, and 5X, respectively) exhibited the same dramatic decrease of wild-type mtDNA observed in the 94B transformant. In particular, in transformant 2SE, the wild-type genomes decreased from 90%o after thawing to 50% after 19 days in culture and to 9% after an additional 7 days (Fig. 2 C and D) . In two other clones (3E1 and 4H1), the proportion of wild-type mtDNA was initially 15% and 6%, respectively, then declined to 2-3% in 7-8 days, and remained at this level over the next 4 weeks (Fig. 2E) subclones showed an apparently homoplasmic wild-type genotype, 1 (subclone 10) exhibited almost pure (--99o%) wild-type mtDNA, and 7 contained predominantly (>81%) mutant mtDNA presumably as a result of a shift in genotype (Fig. 3 A Upper and B) . Second-step subcloning of clone 10 produced 10 clones, of which 8 maintained a nearly homoplasmic wild-type mtDNA for 18 days and the other 2 exhibited the beginning ofa shift to mutant mtDNA (Fig. 3B) . The poor growth ofthe last two clones prevented their further analysis.
In a second 94B subcloning experiment, carried out when the genotype showed 58% wild-type mtDNA, among 10 subclones, 5 subclones still exhibited apparently homoplasmic wild-type mtDNA and 5 contained heteroplasmic mtDNA, with a level of wild-type mtDNA between 8% and 22%. Upon further culturing, the 5 heteroplasmic subclones exhibited a progressive decrease of wild-type mtDNA, to 3.5-7.5% 3 weeks after subcloning (Fig. 3C Upper) . All five apparently homoplasmic wild-type clones exhibited 100% wild-type mtDNA at the earliest analyzed time point (10 days after subcloning), without any evidence of transitional genotype, as opposed to the gradually changing genotype of the subclones shifting to the mutant type. This observation strongly argues that these apparently homoplasmic wild-type clones preexisted as such in the original 94B population. Furthermore, the progressive decline in the poportion of wild-type mtDNA in the 94B mother culture implies that a continuous recruiting of clones shifting to the mutant genotype must have occurred from the pool of apparently homoplasmic wild-type clones.
Quantitation of the mtDNA content in the mother culture at the time of subcloning and in the 10 subclones (Fig. 3C Lower) showed that no significant change in the average amount of mtDNA per cell had occurred between the isolation of the subclones and 2.5 weeks later, when the proportion of wild-type mtDNA in the heteroplasmic subclones had decreased to one-half (Fig. 3C Upper) . This observation indicated that a decrease in the absolute average amount of wild-type mtDNA per cell had taken place in these subclones during the same period. Second-step subcloning of one of the heteroplasmic clones with 4% wild-type mtDNA produced 5 subclones that exhibited limited genotype variability around this value (Fig. 3C Upper) .
Subcloning of the 2SE transformant -5 weeks and =9 weeks after its isolation gave results similar to those described above for 94B (Fig. 4) . For both transformants, the subcloning experiments indicated that the cultures undergoing a shift of their genotype to mutant mtDNA consisted of cell populations that were very heterogeneous in their mutant to wild-type mtDNA ratio and exhibited a progressive general shift toward the mutant genotype, with the proportion of cells containing homoplasmic or near homoplasmic wild-type mtDNA decreasing progressively with the time in culture. These results indicated that the shift toward the mutant type started at different times and/or proceeded at different rates in the individual cells of the unstable populations.
Subcloning of the 94H transformant carried out -9 weeks after its isolation, when the genotype showed -73% wildtype mtDNA, gave 11 subclones that, in contrast to 94B and 2SE, exhibited only limited variability (between 62% and 80%) in wild-type mtDNA content (Fig. 3 A Lower and D) .
The Genotpe Shift Does Not Result from Intercellular Selection Due to Differential Growth Rates. The rapidity of the shift toward mutant mtDNA observed in the unstable cell lines argued strongly against its being caused by cells with more mutant mtDNA growing faster than those with less mutant mtDNA. Evidence against intercellular selection was provided by a comparison of the doubling times of many MELAS transformants exhibiting widely different proportions of mutant mtDNA (Table 1 ). Small differences in doubling times were observed among different clones, probably reflecting variations in nuclear or mtDNA background, or in clone age. However, for a given transformant clone, no significant consistent difference in growth rate was found between stages or subclones homoplasmic or nearly homoplasmic for wild-type mtDNA or stages with 50-70%o wild-type mtDNA and stages or subclones exhibiting nearly homoplasmic or strongly predominant mutant mtDNA. This is dramatically illustrated by 0O0 tAt 33 days after fusion, culture derived from a frozen stock. tAt 63-97 days after fusion. §Derived from subcloning of94B carried out 34 days after fusion (Fig.   3C ).
the experiment shown in Fig. 5 , where 94B' cells, kept in continuous culture for 41 days, exhibited a decrease in the proportion of wild-type mtDNA from 58% to 8%, while maintaining an absolutely constant 24-hr doubling time. Furthermore, even in the cases where a slightly longer doubling time was estimated for cells with mostly wild-type mtDNA, as compared to cells with mostly mutant mtDNA, the increase in percent mutant mtDNA expected as a result of differential growth rates would have been much less than the increase actually observed. Thus, for 2SE cells grown continuously for 26 days, with an observed decrease of wild-type mtDNA from 90% to 9% (Fig. 2D) Fig. 5 are not compatible with a significant role of intercellular selection in the phenomenon investigated here and rather point to an intracellular process involving a replicative advantage of the mutant mtDNA molecules. Genetics: Yoneda et al.
DISCUSSION
The central observation reported here (i.e., the preferential replication of mtDNA molecules carrying the MELAS mutation over wild-type molecules) extends the phenomenon of "ssuppressiveness" to a higher eukaryote mtDNA with a point mutation. Suppressiveness was originally described in yeast for a subclass of "petite" mtDNA mutations (20) and, subsequently, in Neurospora and other filamentous fungi for senescence processes leading to the replacement of normal mtDNA with grossly abnormal mtDNA (21) (22) (23) (24) . In the present work, the evidence obtained excludes a significant role of intercellular selection of faster growing mutant mtDNAenriched cells in the genotype shift observed in unstable heteroplasmic MELAS transformants. The alternative possibility of an unequal segregation of mutant and wild-type mtDNA into daughter cells at cell division, with the daughter cells receiving more mutant mtDNA undergoing a compensatory nonselective mtDNA amplification, seems very unlikely in the present mammalian cell system. In fact, it would require a unidirectionality of unequal segregation events in successive division cycles, for which no known mechanism exists. Therefore, the most reasonable interpretation of the present data is that a replicative advantage of mutant mtDNA molecules over wild-type molecules is the main factor responsible for the observed genotype shift. This replicative advantage may explain the observations made here and in previous work (11, 12) , indicating that the great majority of the transformants obtained by transfer of mitochondria from MELAS patient into p0 cells contained either homoplasmic or near-homoplasmic wild-type mtDNA or strongly predominant mutant mtDNA, with very few transformants exhibiting an intermediate genotype.
As to the mechanism of the phenomenon investigated here, neither a smaller size of the mutant mtDNA molecules (25) nor, presumably, the loss of cis-acting control elements (5) , factors that have been previously considered to explain the accumulation of mtDNA molecules with large deletions in mitochondrial -diseases, could play a role. A plausible mechanism is one involving a feedback phenomenon that induces the selective replication of mtDNA in organelles functionally compromised by the presence of mutated mtDNA. This possibility has been raised before to account for the preferential accumulation of deleted or otherwise grossly altered mtDNA (5, 24) . However, any model-involving selection at the level of individual organelles would have to explain the present findings of two transformants (94H and 4H6) that did not exhibit an amplification of the mutant DNA over [5] [6] weeks. The observation reported here and elsewhere (12) 
